CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
7.37
-0.09 (-1.21%)
Apr 29, 2026, 3:04 PM CST
CSPC Hunan Jingfeng Pharmaceutical Company Description
CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. manufactures and sells chemical drugs and biological agents in China.
The company’s principal product is sodium hyaluronate injection for use in orthopedics and surgery applications.
It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the fields of cardiovascular disease, orthopedic pain disease, tumor disease, women and children.
The company was formerly known as Hunan Jingfeng Pharmaceutical Co.,Ltd. and changed its name to CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. in April 2026.
The company was founded in 1998 and is headquartered in Changde, China.
CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1998 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 547 |
| CEO | Dong Yang |
Contact Details
Address: Shuangchuang Building Changde China | |
| Phone | 86 21 6687 6520 |
| Website | jfzhiyao.com |
Stock Details
| Ticker Symbol | 000908 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000Y11 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Li Zhang | Chairman, Secretary and Director |
| Dong Yang | Non-Independent Director and President |
| Xuehong Ma | Non-Independent Director, Accounting Supervisor and Financial Director |